World News
-
EBD opens its partneringONE Platform for BIO-Europe 2018
World | News | 0 Comment | 29 Oct, 2018
EBD Group (EBD), the market-leading provider of world-class partnering events and tools for the global life science...Read more
-
Elpis human cells can replace animal experiments in Drug Discovery
World | News | 2 Comment | 26 Oct, 2018
Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OP...Read more
-
World | News | 0 Comment | 26 Oct, 2018
M3 Biotechnology, a Seattle-based therapeutics company dedicated to developing, first-in-class, therapies for Alzhe...Read more
-
ICON Wins Pharma Contract Services Company of the Year Award
World | News | 0 Comment | 25 Oct, 2018
ICON plc, (NASDAQ: ICLR) a global provider of drug development services to the pharmaceutical, biotechnology and me...Read more
-
Pfizer, Bain Capital create new company Cerevel Therapeutics
World | News | 0 Comment | 24 Oct, 2018
Bain Capital and Pfizer have announced the creation of Cerevel Therapeutics, a new biopharmaceutical company...Read more
-
AstraZeneca expands collaboration with Innate Pharma
World | News | 0 Comment | 24 Oct, 2018
AstraZeneca, and its global biologics research and development arm MedImmune, have announced a new multi-term agreement ...Read more
-
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain
World | News | 0 Comment | 24 Oct, 2018
Singapore – A non-opioid drug developed by Pfizer and Eli Lilly met the main go...Read more
-
Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering
World | News | 0 Comment | 24 Oct, 2018
Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round led b...Read more
-
Kibow Biotech to exhibit Its "Enteric Dialysis" Technology at ASN 2018
World | News | 0 Comment | 24 Oct, 2018
Kibow Biotech is proud to announce its 21st year of operations as a pioneer with the use of Pro/Prebiotics in people wit...Read more
-
Epilepsy Society, UCL, Congenica unite to identify cause of epileptic death
World | News | 0 Comment | 23 Oct, 2018
Congenica, the global diagnostic decision support platform provider, announced a key partnership with the UK’s&nbs...Read more
-
Stream Bio expands its CPN products distribution network across Europe
World | News | 0 Comment | 23 Oct, 2018
Stream Bio Ltd, a company that develops and manufactures a range of revolutionary bioimaging molecular probes, is expand...Read more
-
AstraZeneca's Lynparza shown to cut cancer progression by 70%
World | News | 0 Comment | 22 Oct, 2018
AstraZeneca and Merck have announced detailed results from the Phase III SOLO-1 trial testing Lynparza (...Read more
-
FDA approves Regeneron, Sanofi's Dupixent for asthma treatment
World | News | 0 Comment | 22 Oct, 2018
Singapore - The FDA approves Regeneron Pharmaceuticals and development partner Sanofi's DUPIXENT (dupilumab) a...Read more
-
Roche's Tecentriq extends progression-free survival in TNBC
World | News | 0 Comment | 22 Oct, 2018
Singapore - Results from a Phase 3 clinical trial, IMpassion130, evaluating Roche unit Genentech's TECENTRIQ (...Read more
-
Luminex to acquire MilliporeSigma’s flow cytometry portfolio
World | News | 0 Comment | 21 Oct, 2018
Luminex has signed a definitive agreement to buy MilliporeSigma’s flow cytometry portfolio for $75 million. This ...Read more
-
NIA releases National Recruitment Strategy to spur dementia based research
World | News | 0 Comment | 20 Oct, 2018
Recruitment and retention in clinical studies for Alzheimer’s disease remains one of the biggest hurdles in the pa...Read more
-
apceth Biopharma announces positive results for apceth-201 in mouse models
World | News | 0 Comment | 19 Oct, 2018
apceth Biopharma GmbH, a company with the mission of improving patients’ lives with next generation cell therapies...Read more
-
Emergent BioSolutions acquires Adapt Pharma
World | News | 0 Comment | 19 Oct, 2018
Adapt Pharma, maker of the naloxone nasal spray Narcan used for the emergency treatment of known or suspected opioid ove...Read more
